1. Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma — a comparison of lipiodol-transcatheter arterial embolization with and without Adriamycin (first cooperative study)

   • Saburo Kawai
   • Jun Okamura
   • The Cooperative Study Group for Liver Cancer Treatment of Japan

   Session I: Treatment for Operable Patients Surgery and Combined Modalities Pages: S1 - S6

2. Clinicopathological study on combination therapy consisting of arterial infusion of lipiodol-dissolved SMANCS and transcatheter arterial embolization for hepatocellular carcinoma

   • Kenji Jinno
   • Shosuke Moriwaki
   • Yoshio Okada

   Session I: Treatment for Operable Patients Surgery and Combined Modalities Pages: S7 - S12

3. Significance of multidisciplinary therapy for hepatocellular carcinoma

   • Yoshifumi Kawarada
   • Takazumi Imai
   • Ryuji Mizumoto

   Session I: Treatment for Operable Patients Surgery and Combined Modalities Pages: S13 - S19

4. Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma — a comparison of L-TAE with Farmorubicin and L-TAE with Adriamycin (second cooperative study)

   • Jun Okamura
   • Saburo Kawai
   • The Cooperative Study Group for Liver Cancer Treatment of Japan

   Session I: Treatment for Operable Patients Surgery and Combined Modalities Pages: S20 - S24

5. Treatment of small hepatocellular carcinoma

   • Takashi Kumada
   • Satoshi Nakano
   • Hideo Okabe

   Session I: Treatment for Operable Patients Surgery and Combined Modalities Pages: S25 - S29

6. Efficacy of combination treatment — (TAE with adriamycin and ethanol) — for hepatocellular carcinoma

   • Yasunori Hasuike
   • Jun Okamura
   • Masami Sakurai

   Session I: Treatment for Operable Patients Surgery and Combined Modalities Pages: S30 - S34

7. Results of hepatic resection and postoperative arterial chemotherapy for hepatocellular carcinoma

   • Akio Harada
   • Toshiaki Nonami
   • Hiroshi Takagi

   Session I: Treatment for Operable Patients Surgery and Combined Modalities Pages: S35 - S37

8. Selection of therapeutic modalities for hepatocellular carcinoma in patients with multiple hepatic lesions

   • Morito Monden
   • Masato Sakon
   • Takesada Mori

   Session I: Treatment for Operable Patients Surgery and Combined Modalities Pages: S38 - S44

9. Transcatheter hepatic arterial chemoembolization using epirubicin-lipiodol: experimental and pharmacological evaluation

   • Seiji Kobayashi
   • Yoshiaki Narimatsu
   • Masaharu Tsuchiya

   Session II: Treatment for Inoperable Patients TACE, Infusion Reservoir and Radiotherapy Pages: S45 - S50

10. Treatment of hepatocellular carcinoma with a CDDP-epirubicin-lipiodol suspension: a pilot clinico-pharmacological study

    • Takafumi Ichida
    • Masashi Kato
    • Hitoshi Asakura

    Session II: Treatment for Inoperable Patients TACE, Infusion Reservoir and Radiotherapy Pages: S51 - S54

11. Evaluation of transcatheter arterial embolization with epirubicin-lipiodol emulsion for hepatocellular carcinoma

    • Keiichi Aoyama
    • Takashi Tsukishiro
    • Akiharu Watanabe

    Session II: Treatment for Inoperable Patients TACE, Infusion Reservoir and Radiotherapy Pages: S55 - S59

12. Assessment of chemoembolization therapy for primary liver cancer using a stabilized Adriamycin-lipiodol suspension

    • Yuji Horiguchi
    • Madoka Itoh
    • Youichi Nagamura

    Session II: Treatment for Inoperable Patients TACE, Infusion Reservoir and Radiotherapy Pages: S60 - S64

13. Comparison of the anticancer effect of ADMOS alone and ADMOS with CDDP in the treatment of hepatocellular carcinoma by intra-arterial injection

    • Koji Ikeda
    • Hiroki Inoue
    • Masayuki Nakajo

    Session II: Treatment for Inoperable Patients TACE, Infusion Reservoir and Radiotherapy Pages: S65 - S68

14. Outcome of localized hepatocellular carcinoma treated with segmental arterioportal chemoembolization

    • Hironobu Nakamura
    • Hiromichi Oi
    • Takahiro Kozuka

    Session II: Treatment for Inoperable Patients TACE, Infusion Reservoir and Radiotherapy Pages: S69 - S71

15. Effectiveness of Lipiodol in transcatheter arterial embolization of hepatocellular carcinoma

    • Norio Nakao
    • Hideo Uchida
    • Osamu Ishida

    Session II: Treatment for Inoperable Patients TACE, Infusion Reservoir and Radiotherapy Pages: S72 - S76

16. Analysis of prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization

    • Keiji Yamamoto
    • Manabu Masuzawa
    • Kazuya Tamura

    Session II: Treatment for Inoperable Patients TACE, Infusion Reservoir and Radiotherapy Pages: S77 - S81

17. Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization and analysis of prognostic factors

    • Ming-Yuh Hsieh
    • Wen-Yu Chang
    • Ding-Kwo Wu

    Session II: Treatment for Inoperable Patients TACE, Infusion Reservoir and Radiotherapy Pages: S82 - S85

18. Transcatheter arterial chemoembolization for hepatocellular carcinoma

    • Chien-Fang Yang
    • Yung-Jen Ho

    Session II: Treatment for Inoperable Patients TACE, Infusion Reservoir and Radiotherapy Pages: S86 - S88

19. Arterial infusion chemotherapy for advanced hepatocellular carcinoma using EPF and EAP therapies

    • Hiraku Yodono
    • Taisuke Sasaki
    • Shoichi D. Takekawa

    Session II: Treatment for Inoperable Patients TACE, Infusion Reservoir and Radiotherapy Pages: S89 - S92

20. Clinical evaluation of intermittent arterial infusion chemotherapy with an implanted reservoir for hepatocellular carcinoma

    • Kenji Nakamura
    • Sumio Takashima
    • Yasuto Onoyama

    Session II: Treatment for Inoperable Patients TACE, Infusion Reservoir and Radiotherapy Pages: S93 - S98

21. Management of patients with unresectable liver metastases from colorectal and gastric cancer employing an implantable port system

    • Yasuaki Arai
    • Tokiko Endo
    • Choichiro Kido

    Session II: Treatment for Inoperable Patients TACE, Infusion Reservoir and Radiotherapy Pages: S99 - S102

22. Radiotherapy in the treatment of hepatocellular carcinoma and its metastases

    • Shinn-Cherng Chen
    • Shi-Long Lian
    • Yau-Hui Ho

    Session II: Treatment for Inoperable Patients TACE, Infusion Reservoir and Radiotherapy Pages: S103 - S105

23. Radiation therapy in patients with unresectable hepatocellular carcinoma

    • Takashi Uno
    • Jun Itami
    • Noboru Arimizu

    Session II: Treatment for Inoperable Patients TACE, Infusion Reservoir and Radiotherapy Pages: S106 - S110

24. Effects of multimodal treatment and hyperthermia on hepatic tumors

    • Yoshimasa Tanaka
    • Keizo Yamamoto
    • Kenji Nagata

    Session II: Treatment for Inoperable Patients TACE, Infusion Reservoir and Radiotherapy Pages: S111 - S114

25. Radiotherapy of cholangiocarcinoma: the roles for primary and adjuvant therapies

    • Takeki Shiina
    • Shuichi Mikuriya
    • Masanao Tani

    Session II: Treatment for Inoperable Patients TACE, Infusion Reservoir and Radiotherapy Pages: S115 - S118

26. Phase II trial for combined external radiotherapy and hyperthermia for unresectable hepatoma

    • Byung Soo Kim
    • Hyun Cheol Chung
    • Gwi Eon Kim

    Session II: Treatment for Inoperable Patients TACE, Infusion Reservoir and Radiotherapy Pages: S119 - S127

27. Treatment of hepatocellular carcinoma by transcatheter hepatic arterial injection of radioactive iodized oil solution

    • Yasuhiro Yumoto
    • Kenji Jinno
    • Takao Tsuji

    Session III: Poster Session Pages: S128 - S136

28. Long-term survival following treatment of hepatocellular carcinoma in Singapore: evaluation of Wellferon in the prophylaxis of high-risk pre-cancerous conditions

    • Chong-Jin Oon

    Session III: Poster Session Pages: S137 - S142

29. Primary liver cancer in Hong Kong

    • Wesely C. T. Shiu

    Session III: Poster Session Pages: S143 - S145

30. Changes in the plasma abnormal prothrombin level following treatment of hepatocellular carcinoma

    • Mitsuo Kusano
    • Masami Nakanishi
    • Michio Mito

    Session III: Poster Session Pages: S146 - S149

31. Clinical aspects and epidemiology of hepatitis B and C viruses in hepatocellular carcinoma in Japan

    • Kendo Kiyosawa
    • Seiichi Furuta

    Plenary Session: State of the Art in Liver Cancer Pages: S150 - S156

32. Liver transplantation for hepatocellular carcinoma: clinical results and future aspects

    • Rudolf Pichlmayr
    • Arved Weimann
    • Burckhardt Ringe

    Plenary Session: State of the Art in Liver Cancer Pages: S157 - S161

33. Liver transplantation in Taiwan: the Chang Gung experience

    • Chao-Long Chen
    • Kuei-Liang Wang
    • Wen-Bin Shieh

    Plenary Session: State of the Art in Liver Cancer Pages: S162 - S165